Côlon & Rectum

, Volume 7, Issue 3, pp 150–155

Prise en charge des cancers du côlon non métastatique chez les patients âgés

Dossier Thématique / Thematic File
  • 85 Downloads

Résumé

Les cancers du côlon atteignent principalement les patients âgés. La prise en charge chirurgicale a fait des progrès mais l’indication d’une chimiothérapie adjuvante reste controversée. Le choix du schéma thérapeutique et la sélection des patients à traiter est un enjeu majeur. Des essais prospectifs spécifiques à la population âgée sont nécessaires.

Mots clés

Cancer du côlon Oncogériatrie Chimiothérapie adjuvante Instabilité microsatellite 

Treatment of metastatic colon cancer in elderly patients

Abstract

Colon cancer occurred mainly in elderly. Improvements have been made in surgery but the indication of chemotherapy remains controversial. The choice of chemotherapy regimen and the selection of the patient to be treated are crucial. Prospective studies specific of elderly are needed.

Keywords

Colon cancer Oncogeriatry Adjuvant chemotherapy Microsatellite instability 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Surgery for colorectal cancer in elderly patients: a systematic review (2000) Colorectal Cancer Collaborative Group. Lancet 356:968–974Google Scholar
  2. 2.
    Faivre J, Lemmens VE, Quipourt V, et al (2007) Management and survival of colorectal cancer in the elderly in populationbased studies. Eur J Cancer 43:2279–2284PubMedCrossRefGoogle Scholar
  3. 3.
    Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, et al (2002) Colon cancer in France: evidence for improvement in management and survival. Gut 51:60–64PubMedCrossRefGoogle Scholar
  4. 4.
    Menotti A, Mulder I, Nissinen A, et al (2001) Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol 54:680–686PubMedCrossRefGoogle Scholar
  5. 5.
    Lewis JH, Kilgore ML, Goldman DP, et al (2003) Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21:1383–1389PubMedCrossRefGoogle Scholar
  6. 6.
    Aparicio T, Navazesh A, Boutron I, et al (2009) Half of elderly patients routinely treated for colorectal cancer receive a substandard treatment. Crit Rev Oncol HematolGoogle Scholar
  7. 7.
    Faivre-Finn C, Bouvier AM, Mitry E, et al (2002) Chemotherapy for colon cancer in a well-defined French population: is it underor over-prescribed? Aliment Pharmacol Ther 16:353–359PubMedCrossRefGoogle Scholar
  8. 8.
    Aparicio T, Bouarioua N, Girard L, et al (2009) Modification par la mise en place d’une Réunion de Concertation Pluridisciplinaire de la prise en charge des patients âgés de 75 ans et plus opérés d’un adénocarcinome colique de stade II ou III. Gastroenterol Clin Biol 33Google Scholar
  9. 9.
    Bennett CL, Greenfield S, Aronow H, et al (1991) Patterns of care related to age of men with prostate cancer. Cancer 67: 2633–2641PubMedCrossRefGoogle Scholar
  10. 10.
    Mahoney T, Kuo YH, Topilow A, et al (2000) Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg 135:182–185PubMedCrossRefGoogle Scholar
  11. 11.
    Extermann M, Albrand G, Chen H, et al (2003) Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol 21:3214–3219PubMedCrossRefGoogle Scholar
  12. 12.
    Yellen SB, Cella DF, Leslie WT (1994) Age and clinical decision making in oncology patients. J Natl Cancer Inst 86:1766–1770PubMedCrossRefGoogle Scholar
  13. 13.
    Caillet P, Canoui-Poitrine F, Vouriot J, et al (2011) Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer: ELCAPA Study. J Clin Oncol 29:3636–3642PubMedCrossRefGoogle Scholar
  14. 14.
    Aparicio T, Jouve JL, Teillet L, et al (2013) Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients. J Clin Oncol 31:1464–1470PubMedCrossRefGoogle Scholar
  15. 15.
    Fossey Diaz V, Girard L, Mielczarek S, et al (2010) Bilan de la mise en place d’une procédure de demande d’avis gériatrique chez des patients âgés atteints de cancers digestifs. J Onco Gériatr 1:93–98Google Scholar
  16. 16.
    Dubreuil O, Cudennec T, Lepere C, et al (2010) Cancers digestifs des patients de plus de 70 ans: quel traitement pour les patients du groupe intermédiaire de Balducci ? JFHODGoogle Scholar
  17. 17.
    Bellera CA, Rainfray M, Mathoulin-Pelissier S, et al (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann OncolGoogle Scholar
  18. 18.
    Aparicio T, Girard L, Bouarioua N, et al (2011) A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study. Crit Rev Oncol Hematol 77:63–69CrossRefGoogle Scholar
  19. 19.
    Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. Oncologist 5:224–237PubMedCrossRefGoogle Scholar
  20. 20.
    Carola E, Chibaudel B, Trager S, et al (2013) Predictive factors for chemotherapy feasibility in elderly patients with solid tumor: Results of GERCOR old prospective multicenter study. J Clin Oncol 31 (suppl; abstr 9511)Google Scholar
  21. 21.
    Attar A, Malka D, Sabate JM, et al (2012) Malnutrition is high and underestimated during chemotherapy in gastrointestinal cancer: an AGEO prospective cross-sectional multicenter study. Nutr Cancer 64:535–542PubMedCrossRefGoogle Scholar
  22. 22.
    Soubeyran P, Fonck M, Blanc-Bisson C, et al (2012) Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 30:1829–1834PubMedCrossRefGoogle Scholar
  23. 23.
    Mitry E, Bouvier AM, Esteve J, et al (2002) Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg 89:1557–1562PubMedCrossRefGoogle Scholar
  24. 24.
    Lemmens VE, Janssen-Heijnen ML, Verheij CD, et al (2005) Comorbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 92:615–623PubMedCrossRefGoogle Scholar
  25. 25.
    Bouvier AM, Launoy G, Lepage C, et al (2005) Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther 22:233–241PubMedCrossRefGoogle Scholar
  26. 26.
    Iwashyna TJ, Lamont EB (2002) Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 20: 3992–3998PubMedCrossRefGoogle Scholar
  27. 27.
    Sargent DJ, Goldberg RM, Jacobson SD, et al (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091–1097PubMedCrossRefGoogle Scholar
  28. 28.
    McCleary J, Meyerhardt J, Green E, et al (2009) Impact of older age on the efficacy of newer adjuvant therapies in >12,500 patients (pts) with stage II/III colon cancer: Findings from the ACCENT Database. J Clin Oncol 27:15sCrossRefGoogle Scholar
  29. 29.
    Tournigand C, Andre T, Bonnetain F, et al (2012) Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol 30:3353–3360PubMedCrossRefGoogle Scholar
  30. 30.
    Quasar Collaborative Group, Gray R, Barnwell J, et al (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370:2020–2029PubMedCrossRefGoogle Scholar
  31. 31.
    Aparicio T, Schischmanoff O, Poupardin C, et al (2013) Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients. Dig Liver Dis 45:245–250PubMedCrossRefGoogle Scholar
  32. 32.
    Sargent DJ, Marsoni S, Monges G, et al (2010) Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 28:3219–3226PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France 2013

Authors and Affiliations

  1. 1.Service de gastroentérologie et cancérologie digestive, hôpital AvicenneHUPSSD, APHPBobignyFrance
  2. 2.Université Paris 13Sorbonne Paris-CitéFrance
  3. 3.Service de chirurgie digestive, hôpital AvicenneHUPSSD, APHPBobignyFrance
  4. 4.Service d’oncologie, hôpital AvicenneHUPSSD, APHPBobignyFrance

Personalised recommendations